| Issue | Title | |
| Vol 13, No 2 (2017) | Advantages of the combined therapy with metformin and glimepiride in patients with type 2 diabetes mellitus | Abstract |
| V.I. Pankiv | ||
| No 1.65 (2015) | Combination Therapy «Metformin + Glimepiride» in Patients with Type 2 Diabetes Mellitus (Molecular Mechanisms for Optimization of the Rehabilitation Effect) | Abstract PDF SUMMARY |
| V.V. Poltorak, N.S. Krasova, M.Yu. Horshunskaia | ||
| Vol 13, No 6 (2017) | Pharmacotherapeutic efficiency and advantages of the combined treatment of patients with type 2 diabetes mellitus | Abstract |
| V.I. Pankiv | ||
| No 5.77 (2016) | Effect of Combination Therapy with Extended-Release Metformine and Glimepiride on Carbohydrate and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus | Abstract |
| V.I. Pankiv | ||
| No 5.69 (2015) | Amaryl®М SR: a New Release Form, New Possibilities for The Patients | Abstract PDF SUMMARY |
| V.V. Роltorak, M.Yu. Gorshunska, N.S. Krasova | ||
| No 4.68 (2015) | Combined Therapy with Antihyperglycemic Oral Agents (Metformin, Sulfonylureas) and Insulin in the Management of Type 2 Diabetic Patients (Pathogenic Substantiation and Clinical Utility) | Abstract |
| M.Yu. Horshunskaia | ||
| No 8.56 (2013) | Individual Approach to the Treatment of Diabetes Mellitus Type 2: When, to Whom and What are the Alternative Options Besides Metformin | Abstract |
| V.I. Pankiv | ||
| No 3.51 (2013) | Safety and Clinical Efficiency of Using Combined Preparation of Metformin Extended-Release and Glimepiride | Abstract |
| V.I. Pankiv | ||
| No 6.78 (2016) | Voglibose in Combination of Three Hypoglycemic Agents in the Treatment of Type 2 Diabetes Mellitus | Abstract |
| V.I. Pankivn, I.V. Cherniavska | ||
| No 5.61 (2014) | Adiponectin and Diabetes Mellitus Type 2 (Pathogenic Aspects as the Ground for Antidiabetic Pharmacotherapy Optimization) | Abstract |
| V.V. Роltorak, M.Yu. Gorshunska, N.S. Krasova | ||
| No 2.58 (2014) | The Many Faces of Glimepiride: on the Question of Interchangeability of Oral Hypoglycemic Agents | Abstract |
| N.V. Bezdetko | ||
| No 1.57 (2014) | Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation) | Abstract |
| V.V. Poltorak, N.A. Kravchun, M.Yu. Gorshunskaya, N.S. Krasova | ||
| No 3.67 (2015) | Influence of Fixed Combination of Metformin SR and Glimepiride on Carbohydrate, Lipid Metabolism and Arterial Wall Stiffness in Patients with Diabetes Mellitus Type 2 | Abstract |
| O.S. Larin, K.O. Zuiev, D.H. Kohut | ||
| 1 - 13 of 13 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default only articles containing all terms in the query are returned (i.e., AND is implied)
- Combine multiple words with OR to find articles containing either term; e.g., education OR research
- Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
- Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
- Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"
